Phapros Tbk PT - Asset Resilience Ratio

Latest as of March 2025: 0.03%

Phapros Tbk PT (PEHA) has an Asset Resilience Ratio of 0.03% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Phapros Tbk PT total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Rp400.00 Million
≈ $23.44K USD Cash + Short-term Investments

Total Assets

Rp1.47 Trillion
≈ $86.36 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2011–2024)

This chart shows how Phapros Tbk PT's Asset Resilience Ratio has changed over time. See PEHA net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Phapros Tbk PT's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Phapros Tbk PT (PEHA) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rp400.00 Million 0.03%
Short-term Investments Rp0.00 0%
Total Liquid Assets Rp400.00 Million 0.03%

Asset Resilience Insights

  • Limited Liquidity: Phapros Tbk PT maintains only 0.03% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Phapros Tbk PT Industry Peers by Asset Resilience Ratio

Compare Phapros Tbk PT's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
Drug Manufacturers - Specialty & Generic 43.05%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
Drug Manufacturers - Specialty & Generic 1.96%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Guobang Pharma Ltd
SHG:605507
Drug Manufacturers - Specialty & Generic 8.47%

Annual Asset Resilience Ratio for Phapros Tbk PT (2011–2024)

The table below shows the annual Asset Resilience Ratio data for Phapros Tbk PT.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.03% Rp400.00 Million
≈ $23.44K
Rp1.43 Trillion
≈ $83.79 Million
-0.16pp
2023-12-31 0.19% Rp3.40 Billion
≈ $199.23K
Rp1.77 Trillion
≈ $103.47 Million
+4.47pp
2022-12-31 -4.28% Rp-77.25 Billion
≈ $-4.53 Million
Rp1.81 Trillion
≈ $105.84 Million
-0.08pp
2021-12-31 -4.20% Rp-77.15 Billion
≈ $-4.52 Million
Rp1.84 Trillion
≈ $107.73 Million
-2.84pp
2020-12-31 -1.36% Rp-26.01 Billion
≈ $-1.52 Million
Rp1.92 Trillion
≈ $112.27 Million
-3.89pp
2019-12-31 2.54% Rp53.18 Billion
≈ $3.12 Million
Rp2.10 Trillion
≈ $122.86 Million
+2.64pp
2018-12-31 -0.11% Rp-1.97 Billion
≈ $-115.14K
Rp1.87 Trillion
≈ $109.50 Million
-11.18pp
2017-12-31 11.08% Rp130.25 Billion
≈ $7.63 Million
Rp1.18 Trillion
≈ $68.91 Million
+11.66pp
2013-12-31 -0.59% Rp-3.76 Billion
≈ $-220.58K
Rp643.09 Billion
≈ $37.68 Million
+0.07pp
2012-12-31 -0.66% Rp-3.66 Billion
≈ $-214.69K
Rp558.64 Billion
≈ $32.73 Million
+0.19pp
2011-12-31 -0.84% Rp-3.90 Billion
≈ $-228.29K
Rp462.59 Billion
≈ $27.11 Million
--
pp = percentage points

About Phapros Tbk PT

JK:PEHA Indonesia Drug Manufacturers - Specialty & Generic
Market Cap
$14.67 Million
Rp250.32 Billion IDR
Market Cap Rank
#25910 Global
#582 in Indonesia
Share Price
Rp298.00
Change (1 day)
-0.67%
52-Week Range
Rp260.00 - Rp364.00
All Time High
Rp2996.89
About

PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, X-Gra, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also pr… Read more